Random Synchronous Malignancy in Male Breast: A Case Report

Sarma, Manjit; Borde, Chaitanya; Subramanyam, Padma; Sundaram, P. V.

doi:10.4048/jbc.2013.16.4.442

Cited by 10 publications

(12 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…31 The relative lack of glandular activity in the male breast potentially increases the sensitivity of FDG PET/CT for detection of male breast cancer. 70 , 71 Groheux et al have reported that FDG PET/CT seems to be a powerful imaging method to perform staging, restaging, and treatment response assessment in male patients with breast carcinoma. They found that all the estrogen receptor positive breast carcinomas were FDG-avid (Fig.…”

Section: Diseases Of the Male Breastmentioning

confidence: 99%

Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT

Dong

Wang

et al. 2016

Clinical Nuclear Medicine

View full text Add to dashboard Cite

Interpretation of 18F-FDG PET/CT studies in breast is challenging owing to nonspecific FDG uptake in various benign and malignant conditions. Benign conditions include breast changes in pregnancy and lactation, gynecomastia, mastitis, fat necrosis, fibroadenoma, intraductal papilloma, and atypical ductal hyperplasia. Among malignancies, invasive ductal carcinoma and invasive lobular carcinoma are common histological types of breast carcinoma. Rarely, other unusual histological types of breast carcinomas (eg, intraductal papillary carcinoma, invasive micropapillary carcinoma, medullary carcinoma, mucinous carcinoma, and metaplastic carcinoma), lymphoma, and metastasis can be the causes. Knowledge of a wide spectrum of hypermetabolic breast lesions on FDG PET/CT is essential in accurate reading of FDG PET/CT. The purpose of this atlas article is to demonstrate features of various breast lesions encountered at our institution, both benign and malignant, which can result in hypermetabolism on FDG PET/CT imaging.

show abstract

Section: Diseases Of the Male Breastmentioning

confidence: 99%

Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT

Dong

Wang

et al. 2016

Clinical Nuclear Medicine

View full text Add to dashboard Cite

show abstract

“…The two tumors must be sufficiently distant from each other, 3) It should be excluded with certainty that the second tumor is not the metastasis of the index tumor (6). Synchronous tumors in our case fulfilled all three criteria.…”

Section: Discussionmentioning

confidence: 78%

Co-existent breast and renal cancer

Üreyen

Dadalı

Akdeniz

et al. 2015

UCD

View full text Add to dashboard Cite

The concomitant presence of breast cancer with one or more other types of cancer such as colon, vulva, lung, larynx, liver, uterus and kidneys has been presented in the literature. However, synchronous breast and renal cancer is very uncommon. Herein we present a woman with synchronous breast and renal cancer, and review the literature. A 77-year-old post-menopausal woman was admitted to our clinic complaining of left sided breast mass. On physical examination, there was a 3 cm palpable mass in the upper outer quadrant of the left breast along with a conglomerate of lymph nodes in the left axilla. Ultrasonography and mammography showed a 3 cm solid, hypoechoic mass in the upper outer quadrant and left axillary lymphadenopathy. The tru-cut biopsy of the lesion revealed invasive ductal carcinoma. The bone scintigraphy, thoracic and cranial computerized tomographies were normal. The abdominal computerized tomography identified a 3x3 cm solid renal mass with heterogeneous contrast enhancement in the posterior segment of the lower pole, which was suspicious for renal cell carcinoma. Breast conserving surgery and axillary lymph node dissection was performed, and the pathology specimen demonstrated invasive ductal carcinoma. The patient was discharged on postoperative day 5. Three weeks later partial nephrectomy was performed by urology department for the solid renal mass, and the pathology result showed clear cell-renal carcinoma with Fuhrman grade 3. The patient is being followed-up for renal carcinoma, and underwent radiotherapy for breast cancer. Hormonotherapy for breast cancer is still continuing.

show abstract

“…Multiple primary carcinoma descriptions are provided with the following criteria: each malignant tumor must bear histological features; they must be different from each other histologically; exclusion must be done as they are not metastasis of each other [3].…”

Section: Discussionmentioning

confidence: 99%

Metachronous infiltration of bone marrow due to breast cancer and multiple myeloma

Peker¹,

Yarkıcı²,

Uğur³

et al. 2017

The European Research Journal

View full text Add to dashboard Cite

Multiple primary tumors are rarely seen in clinical practice. Cases of metastatic breast cancer associated with multiple myeloma were rare in the literature. It is believed that simultaneously observed bone marrow involvement due to breast cancer and multiple myeloma is sporadic. We present a 49-year-old female patient with metastatic breast cancer who developed multiple myeloma during breast cancer treatment.Eur Res J 2018;4(2):136-139

show abstract

Random Synchronous Malignancy in Male Breast: A Case Report

Cited by 10 publications

References 13 publications

Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT

Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT

Co-existent breast and renal cancer

Metachronous infiltration of bone marrow due to breast cancer and multiple myeloma

Contact Info

Product

Resources

About